Scout | CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)

This grant opportunity supports research focused on discovering new treatments for severe health effects caused by exposure to highly toxic chemicals, which could result from terrorist attacks or industrial accidents. The research aims to develop and test potential new drugs or treatment strategies, which could include repurposing existing FDA-approved products. The goal is to produce prelimin…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $275,000

Funding Amount: $275,000

Dates

Open for Submission: March 22, 2023

Submission Deadline: May 30, 2025

Opportunity Released: March 22, 2023

Application Window Closes: May 30, 2025

Keywords

Translational research

medical countermeasures

chemical threats

toxic compounds

novel treatment strategies

preclinical development

biologics

FDA-approved repurposing

NIH CounterACT

acute exposure.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers